<DOC>
	<DOCNO>NCT00706004</DOCNO>
	<brief_summary>The purpose study determine short term safety effectiveness lubiprostone use constipation adult cystic fibrosis .</brief_summary>
	<brief_title>Short Term Safety Efficacy Lubiprostone Adults With Cystic Fibrosis</brief_title>
	<detailed_description>Cystic fibrosis ( CF ) affect 30,000 people United States . It cause absent dysfunctional protein call CF transmembrane conductance regulator ( CFTR ) function chloride channel . Lubiprostone medication indicate constipation activates type 2 chloride channel ( ClC-2 ) potential effective treatment constipation adult CF . It potential correct underlie disorder utilize chloride channel whose activity depend CFTR . This project prospective open-label pilot study examine safety effectiveness lubiprostone use adult CF constipation . The specific aim follow : 1 ) Determine effectiveness lubiprostone constipation participant CF , 2 ) Determine short term safety lubiprostone adult CF . Data also collect generate information effect lubiprostone nutritional status .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>Men woman race 18 year age old time enrollment Diagnosis cystic fibrosis History constipation , define Rome III criterion , OR requirement chronic schedule dos laxative , OR score ≥1.5 Patient assessment constipation symptom ( PACSYM ) 15 survey administer screening visit , OR score less 3 Bristol Stool Scale ( BSS ) screen visit . Current gastrointestinal ( GI ) obstruction History GI obstruction require hospitalization within six month enrollment Pregnancy breastfeed Hypersensitivity lubiprostone component Serum creatinine &gt; 1.8 mg/dL last annual visit Clinically significant liver disease , define aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &gt; 3X upper limit normal History frequent hospital admission CF exacerbation ( ≥4 last 6 month ) Currently register lung transplant wait list Women capable childbearing either refuse pregnancy test , incapable unwilling use contraception protocol , . Any condition , opinion investigator , interfere ability participant comply study requirement , confers significant risk participant , limit ability participant complete study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>constipation</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>lubiprostone</keyword>
	<keyword>Constipation adult cystic fibrosis</keyword>
</DOC>